.svg){kind=logo}
.svg){kind=icon}
MDGH in the news
Therapeutic vaccine trials to start in London, UK
June 7, 2010
Medicines Development is currently coordinating an international collaboration between Opal Therapeutics Inc. (Opal) and Massachusetts General Hospital (MGH) to develop a novel immunotherapy to treat HIV.
The collaboration involves the Ragon Institute of MGH, MIT and Harvard, Oxford University and the St Stephen’s AIDS Trust (Chelsea and Westminster Hospital). The first in human clinical trial is currently being conducted in London Sponsored by Medicines Development.
REFERENCES
Stay up to date
Follow our work by signing up for our newsletter
MDGH respectfully acknowledges the Traditional Owners of the land on which our office is located, the Wurundjeri people of the Kulin Nation, and pay our respect to their Elders past, present and emerging.
Medicines Development for Global Health Limited.
Level 1, 18 Kavanagh Street Southbank Victoria 3006 Australia.
ABN: 79 116 977 523